New Hybrid Hearing Device Expands Treatment Options For People With Ski-Slope Hearing Loss
Executive Summary
Cochlear Americas launched the Cochlear Nucleus Hybrid Implant System in the US market in May 2014, a first-of-its kind technology that integrates the functions of a hearing aid and cochlear implant in a single device.
You may also be interested in...
US FDA Approves First Telehealth Option To Remotely Program Cochlear Implants
FDA approved a PMA supplement to remotely program sessions for Cochlear Americas' Nucleus Cochlear Implant System, heralding the feature as the first programming telehealth option for the hearing implants.
A Boom in Devices for the Hearing Impaired
Competition is spurring innovation in the hearing aid market and providers are excited at the prospect of adopting new products that can improve on existing treatments. The hottest area at the moment is implantable hearing aid devices. It's not a new concept, but it's one that many believe will command a significant share of the market.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.